Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:30 AM UTC
| NCT Number | NCT07379827 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | Clinical Trial |
| Target Enrollment | 1,500 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | June 18, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07379827 is currently recruiting participants. This clinical trial study for schizophrenia is actively seeking new participants at 52 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07379827 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07379827 was last updated 3 weeks ago (June 18, 2026). HelloStudys verifies this status automatically.